Ameriprise’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-17,995
| Closed | -$398K | – | 3985 |
|
|
2021
Q1 | $398K | Buy |
17,995
+35
| +0.2% | +$774 | ﹤0.01% | 3484 |
|
|
2020
Q4 | $556K | Buy |
17,960
+1,230
| +7% | +$38.1K | ﹤0.01% | 3299 |
|
|
2020
Q3 | $340K | Buy |
16,730
+4,155
| +33% | +$84.4K | ﹤0.01% | 3383 |
|
|
2020
Q2 | $193K | Sell |
12,575
-25,560
| -67% | -$392K | ﹤0.01% | 3500 |
|
|
2020
Q1 | $295K | Sell |
38,135
-1,080
| -3% | -$8.36K | ﹤0.01% | 3308 |
|
|
2019
Q4 | $560K | Sell |
39,215
-1,395
| -3% | -$19.9K | ﹤0.01% | 3295 |
|
|
2019
Q3 | $610K | Sell |
40,610
-79,990
| -66% | -$1.2M | ﹤0.01% | 3226 |
|
|
2019
Q2 | $1.73M | Sell |
120,600
-17,196
| -12% | -$246K | ﹤0.01% | 2834 |
|
|
2019
Q1 | $2.4M | Buy |
+137,796
| New | +$2.4M | ﹤0.01% | 2652 |
|